CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,091 enrolled
Drug / intervention
Dexmedetomidinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05163704
NCT05163704N/ACompleted
CompareCT.gov

Safe Sedation of Children During Radiological Examinations

Karolinska University Hospital·interventional·Posted Dec 20, 2021·Updated Dec 20, 2021

In Brief

A clinical study evaluating Dexmedetomidine for Deep Sedation. Completed, enrolled 1,091 participants across 1 site.

Detailed Summary

Dexmedetomidine, has been used in the past 4-5 years as an alternative sedation method for children at the pediatric radiology department in order to reduce the waiting lists and the use of general anesthesia with its risks and side effects in magnetic resonance and computed tomography examinations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Sedation
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 20, 2021
Enrollment StartNov 1, 2017
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 4.5 years ago

Interventions

Dexmedetomidinedrug

Dexmedetomidine is a beneficial sedative for children. It provides a sedation equivalent to a natural deep sleep with negligible respiratory effects. Administration via the nose provides better absorption and faster impact effect. The drug does not taste and does not sting when administered.